Several small natural compounds such as brassinin42, resveratrol25, and quercetin40 have safely achieved AKT inhibition in cancer models including CRC, without causing the cytotoxic effects associated with the conventional therapies43, but their potency is still questionable as their viability is largely subject to combination with existing conventional therapies43. The gene discussed is AKT1; the disease is cancer.